Detailed answers about ADAMS & JAMIESON SECURE MEDICAL SOLUTIONS LTD, including incorporation, status, business activity, and accounts information.
When was ADAMS & JAMIESON SECURE MEDICAL SOLUTIONS LTD founded?
ADAMS & JAMIESON SECURE MEDICAL SOLUTIONS LTD was officially incorporated on 23 December 2022 and is registered under company number SC753734. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ADAMS & JAMIESON SECURE MEDICAL SOLUTIONS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ADAMS & JAMIESON SECURE MEDICAL SOLUTIONS LTD?
ADAMS & JAMIESON SECURE MEDICAL SOLUTIONS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ADAMS & JAMIESON SECURE MEDICAL SOLUTIONS LTD do?
ADAMS & JAMIESON SECURE MEDICAL SOLUTIONS LTD operates in the following sector: 86220 - Specialists medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is ADAMS & JAMIESON SECURE MEDICAL SOLUTIONS LTD's registered address?
The registered office address of ADAMS & JAMIESON SECURE MEDICAL SOLUTIONS LTD is 1 SIMONSBURN ROAD, KILMARNOCK, AYRSHIRE, UNITED KINGDOM, KA1 5LA. This is the official address filed with Companies House for legal and statutory correspondence.
Is ADAMS & JAMIESON SECURE MEDICAL SOLUTIONS LTD financially stable?
The most recent accounts for ADAMS & JAMIESON SECURE MEDICAL SOLUTIONS LTD were made up to 31 December 2024, filed as MICRO ENTITY. Next accounts are due by 30 September 2026.